No Data
No Data
Guichuangtongqiao-B(02190.HK) cancelled 2.219 million repurchased shares on July 31.
On July 31st, GeLonghui reported that Guichuangtongqiao-B (02190.HK) will cancel 2.219 million shares of repurchased stocks on July 31, 2024.
Zylox-Tonbridge Medical Technology to Swing to H1 Profit
Guichuang Tongqiao-B (02190.HK) Profit: expected to make a profit of no less than 50 million yuan in the first half of the year, turning losses around year-on-year.
On July 29th, GeLongHui reported that GuiChuangTongQiao-B(02190.HK) group expects to achieve revenue of no less than RMB 0.36 billion in the six months ending on June 30, 2024 (the 'report period'), an increase of no less than about 56.5% compared to RMB 0.2301 billion for the six months ending on June 30, 2023 based on the review of the preliminary unaudited comprehensive management accounts of the group. The company also expects to record a net profit attributable to equity holders of the company of no less than RMB 50 million, while for the six months ending on June 30, 2023, it was a net loss of approximately RMB 35.5 million.
Express News | Zylox-Tonbridge Medical Technology Co Ltd Sees Revenue of Not Less Than RMB360.0 Mln for Hy
ZYLOXTB-B: POSITIVE PROFIT ALERT
Guichuang Tongqiao-B (02190.HK) plans to hold a board of directors meeting on August 20th to review its mid-term performance.
Guichuang Tongqiao-B (02190.HK) announced on July 26th that the board of directors will hold a meeting on August 20th, 2024 (Tuesday) to review and approve the company and its subsidiaries' mid-term performance for the six months ending on June 30th, 2024, as well as to handle other matters.
No Data